19-35034040-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000415950.5(SCN1B):​c.749G>C​(p.Arg250Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,549,996 control chromosomes in the GnomAD database, including 16,715 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.13 ( 1462 hom., cov: 32)
Exomes 𝑓: 0.14 ( 15253 hom. )

Consequence

SCN1B
ENST00000415950.5 missense

Scores

1
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.409

Publications

31 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036869943).
BP6
Variant 19-35034040-G-C is Benign according to our data. Variant chr19-35034040-G-C is described in ClinVar as Benign. ClinVar VariationId is 36756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000415950.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
NM_001037.5
MANE Select
c.448+301G>C
intron
N/ANP_001028.1
SCN1B
NM_199037.5
c.749G>Cp.Arg250Thr
missense
Exon 3 of 3NP_950238.1
SCN1B
NM_001321605.2
c.349+301G>C
intron
N/ANP_001308534.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
ENST00000415950.5
TSL:1
c.749G>Cp.Arg250Thr
missense
Exon 3 of 3ENSP00000396915.2
SCN1B
ENST00000262631.11
TSL:1 MANE Select
c.448+301G>C
intron
N/AENSP00000262631.3
SCN1B
ENST00000638536.1
TSL:1
c.448+301G>C
intron
N/AENSP00000492022.1

Frequencies

GnomAD3 genomes
AF:
0.132
AC:
20133
AN:
151974
Hom.:
1465
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0634
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.259
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.155
Gnomad OTH
AF:
0.166
GnomAD2 exomes
AF:
0.144
AC:
22249
AN:
154732
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.0617
Gnomad AMR exome
AF:
0.0872
Gnomad ASJ exome
AF:
0.256
Gnomad EAS exome
AF:
0.213
Gnomad FIN exome
AF:
0.183
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.156
GnomAD4 exome
AF:
0.143
AC:
199879
AN:
1397904
Hom.:
15253
Cov.:
31
AF XY:
0.144
AC XY:
98954
AN XY:
689562
show subpopulations
African (AFR)
AF:
0.0596
AC:
1883
AN:
31572
American (AMR)
AF:
0.0925
AC:
3303
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
6627
AN:
25166
East Asian (EAS)
AF:
0.195
AC:
6964
AN:
35732
South Asian (SAS)
AF:
0.114
AC:
8996
AN:
79200
European-Finnish (FIN)
AF:
0.180
AC:
8851
AN:
49262
Middle Eastern (MID)
AF:
0.188
AC:
1072
AN:
5698
European-Non Finnish (NFE)
AF:
0.142
AC:
153270
AN:
1077626
Other (OTH)
AF:
0.154
AC:
8913
AN:
57950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7404
14809
22213
29618
37022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5378
10756
16134
21512
26890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.132
AC:
20122
AN:
152092
Hom.:
1462
Cov.:
32
AF XY:
0.134
AC XY:
9993
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0633
AC:
2629
AN:
41528
American (AMR)
AF:
0.133
AC:
2027
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.259
AC:
896
AN:
3466
East Asian (EAS)
AF:
0.198
AC:
1019
AN:
5154
South Asian (SAS)
AF:
0.112
AC:
536
AN:
4786
European-Finnish (FIN)
AF:
0.189
AC:
1997
AN:
10594
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.155
AC:
10509
AN:
67958
Other (OTH)
AF:
0.164
AC:
347
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
914
1828
2741
3655
4569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
298
Bravo
AF:
0.127
TwinsUK
AF:
0.132
AC:
490
ALSPAC
AF:
0.146
AC:
561
ESP6500AA
AF:
0.0602
AC:
136
ESP6500EA
AF:
0.145
AC:
639
ExAC
AF:
0.0970
AC:
3853

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 22, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 29. Only high quality variants are reported.

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Brugada syndrome 5 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cardiac arrhythmia Benign:1
Apr 22, 2013
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
11
DANN
Benign
0.93
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.096
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.41
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.010
N
REVEL
Benign
0.047
Sift
Pathogenic
0.0
D
Polyphen
0.22
B
Vest4
0.096
MPC
1.4
ClinPred
0.013
T
GERP RS
1.8
gMVP
0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67486287; hg19: chr19-35524944; COSMIC: COSV52895059; COSMIC: COSV52895059; API